Evolving drug regulatory landscape in China: A clinical pharmacology perspective

• Main Authors: Weifeng Tang (Author), Ying Huang (Author), Diansong Zhou (Author), Yao Huang (Author), Yingxue Chen (Author), Song Ren (Author), Yan Li (Author), Shengqian Wu (Author), Xiaoying Zhao (Author), Xuyang Song (Author), Haidong Wang (Author), Yuwen Jin (Author), Hongtao Yu (Author), Li Zhang (Author), Yunfei Li (Author), David Boulton (Author), Kevin Shen (Author)
• Format: Book
• Published: Wiley, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract In order to encourage innovative medicine to address Chinese unmet medical needs, China has changed its drug regulatory landscape to speed up access to new medicines. In order to understand the fast‐changing landscape and to enable planning of more global drug development programs and study...